Inflammatory bowel disease

In short

Coloscopy is central to the care of Crohn's disease and ulcerative colitis — for diagnosis, for monitoring how well treatment is controlling inflammation, and for cancer surveillance, which is a different question with different rules from population screening. The test itself is the same procedure, but several things around it are tailored: the timing relative to a flare, the bowel preparation, what the endoscopist looks at and biopsies, and how often you return.

What this page covers

How coloscopy is used in inflammatory bowel disease (IBD), how surveillance differs from screening, what chromoendoscopy is, how to think about a flare, and the practical adjustments that matter for prep and recovery.

Why the test is done and what the endoscopist is assessing
Surveillance for colorectal cancer in long-standing colitis
Chromoendoscopy and high-definition white-light imaging
Doing prep when you have IBD — practical adjustments
Coloscopy during a flare
Medications around the test

Why coloscopy matters in IBD

In ulcerative colitis the colon and rectum carry the disease; in Crohn's disease the inflammation can appear anywhere from the mouth to the anus, but the terminal ileum (the last part of the small intestine) and the colon are the most common sites. Coloscopy lets the endoscopist see the lining directly, take small tissue samples (biopsies), measure how far the inflammation extends, and judge severity using validated scoring systems such as the Mayo endoscopic subscore in ulcerative colitis or the Simple Endoscopic Score for Crohn's Disease (SES-CD).

Three broad uses are typical. First, diagnosis — distinguishing IBD from infection, irritable bowel syndrome, microscopic colitis, and ischaemic colitis, and separating Crohn's disease from ulcerative colitis where possible. Second, monitoring response to treatment — what gastroenterologists now call treat-to-target, with the target being mucosal healing rather than only how you feel. Third, surveillance for dysplasia (precancerous change) and cancer in people with long-standing colitis.

Surveillance is not the same as screening

People without IBD start screening at an age set by guidelines and continue at intervals largely determined by what is found at the first test. People with long-standing colitis follow a different track. The reason is that chronic colonic inflammation, sustained over years, is itself a risk factor for colorectal cancer, and the cancer that arises in colitis can look different — flatter, harder to spot, and not always confined to discrete polyps.

Major society guidance (the American College of Gastroenterology, the American Gastroenterological Association, the British Society of Gastroenterology, and the European Crohn's and Colitis Organisation) converges on a few common principles. A first surveillance coloscopy is generally recommended around eight to ten years after symptoms began for people with extensive colitis, and risk is then re-stratified based on extent of disease, presence of primary sclerosing cholangitis, family history of colorectal cancer, severity of past inflammation, and findings such as strictures, post-inflammatory polyps, or any prior dysplasia. Subsequent intervals are shorter when risk is higher.

Some details vary between societies and between countries, so the exact interval recommended for you should come from your gastroenterologist with your specific history in front of them. The key idea is that the surveillance schedule is individualised — it is not the same as the every-ten-years cadence that healthy adults follow after a clean screening test.

Chromoendoscopy and what the endoscopist looks for

Surveillance in colitis is more painstaking than a typical screening exam. Two visualisation approaches are in routine use.

The first is high-definition white-light coloscopy with careful, slow withdrawal and biopsies of any visible abnormality. The second is chromoendoscopy, in which a dilute blue dye (most often methylene blue or indigo carmine) is sprayed onto the bowel surface during the examination. The dye settles into surface irregularities and makes flat lesions easier to see. Some units also use virtual chromoendoscopy — electronic filters built into modern scopes (Narrow Band Imaging, Blue Light Imaging, Linked Colour Imaging) that change how the light is rendered without dye.

The American Gastroenterological Association and European Crohn's and Colitis Organisation have endorsed chromoendoscopy as a reasonable approach for surveillance in colitis, particularly in centres with experience. Random biopsies (multiple samples taken at set distances throughout the colon) used to be standard everywhere; many units have moved towards targeted biopsies of visible lesions when chromoendoscopy is used. Practice differs; what your unit does should be a question you can ask.

Bowel preparation when you have IBD

Good views matter even more in IBD surveillance than in routine screening, because dysplasia in colitis can be flat and subtle. The preparation itself is the same family of solutions used by other patients (see PEG-based preps, sulfate preps, and low-volume options), but a few practical points come up often.

Active inflammation makes the bowel more sensitive. Cramping during prep is common and usually tolerable; some patients find slower sipping more comfortable than the standard pace. People with significant strictures (narrowed segments) or active severe colitis may be advised to use a particular prep, or to stop and call if a specific symptom appears. People with an ileostomy or a J-pouch will have a different protocol entirely — discuss this directly with the team that knows your anatomy.

Stoma output increases dramatically during prep; have spare bags and a plan. People with perianal Crohn's disease often find barrier creams during prep helpful for skin protection. None of this is unusual to the team, and it is worth telling them in advance so the day works smoothly.

Coloscopy during a flare

A flare can be a reason to do a coloscopy or a reason not to do one — it depends on the question being asked. If your team needs to know how severe an acute flare is, whether it is being driven by IBD itself or by an infection such as Clostridioides difficile or cytomegalovirus, or whether surgery should be considered, a flexible sigmoidoscopy or limited coloscopy with biopsies is often the right test. These limited examinations are typically done with minimal preparation because severe inflammation perforates more easily and a full prep adds risk.

If, on the other hand, the question is whether your maintenance treatment is working over time, that surveillance is best done when you are in stable remission. The endoscopist's view is more accurate when inflammation is quiet, and the small risk of the procedure is lower.

Medications around the test

This is a question for your prescribing clinician, not a page on the internet. As a general orientation, mesalamine, immunomodulators, and biologic medications used for IBD are usually continued through coloscopy without change. Corticosteroids are continued. Decisions about anticoagulants, antiplatelets, and weight-loss medications follow the same logic as for anyone else (see blood thinners and antiplatelets and GLP-1 medications).

Two specific points are worth raising directly with your gastroenterologist. If you take a biologic on a fixed schedule, it is reasonable to ask whether scheduling the coloscopy near the dose makes any difference for you (most often it does not). And if you are anaemic from your IBD or have had recent bleeding, the team may want a current haemoglobin before the test.

What to ask your clinician

What is the purpose of this coloscopy — diagnosis, treatment monitoring, surveillance, or something else?
Given my disease extent and duration, what surveillance interval makes sense for me?
Does this unit offer chromoendoscopy or high-definition imaging for IBD surveillance?
Will biopsies be targeted to visible lesions, random throughout the colon, or both?
Should I do this test in remission, or is now the right time?
Do my IBD medications need any adjustment around the procedure?
Is there a particular bowel preparation you prefer for someone with my disease?
If I have a stricture, how will that change the plan for the test or for prep?

Common worries, briefly addressed

Will the prep set off a flare?

It can produce loose stool, cramping, and urgency that feel flare-like during the prep itself, and that resolve quickly afterwards. A genuine flare triggered by prep is uncommon but described, particularly with high-volume osmotic preparations in people with brittle disease. If you have a history of this, raise it before booking — your team may suggest a different prep or a different schedule.

If I have a stricture, can a coloscopy still be done?

Often yes, with a smaller-diameter scope. Some strictures are too tight for the standard adult coloscope; a paediatric or thin scope is sometimes used, and in selected cases a balloon dilation is performed during the test. Your gastroenterologist will know what your imaging shows.

I have a J-pouch — is this still called a coloscopy?

The procedure is called a pouchoscopy when only the pouch is examined; a fuller examination of any retained small intestine is sometimes added. The principles are similar: surveillance, monitoring inflammation (pouchitis or cuffitis), and managing complications. Prep and sedation are gentler than for a full colon, and the test is often shorter.

How often will I need this for the rest of my life?

That depends on how long you have had colitis, how much of the colon is involved, whether you have primary sclerosing cholangitis, and what is found over time. Some patients return every one to two years; others every three to five. The schedule is reviewed each time and can change as your risk does.

Can I see the pictures and pathology report?

Yes. You are entitled to copies of the procedure report and the pathology report, and reading them — alongside your gastroenterologist's interpretation — is one of the most useful things people with IBD can do for themselves over time.

Sources

American College of Gastroenterology — clinical guidelines on the management of ulcerative colitis and Crohn's disease in adults
American Gastroenterological Association — guidance on endoscopic surveillance and management of dysplasia in inflammatory bowel disease
British Society of Gastroenterology — consensus guidelines on the management of inflammatory bowel disease in adults
European Crohn's and Colitis Organisation — guidelines on diagnostic assessment and surveillance in IBD
Crohn's & Colitis Foundation; Crohn's & Colitis UK — patient information on coloscopy and surveillance
National Institute for Health and Care Excellence — guidance on Crohn's disease and ulcerative colitis